Full Tech Transfer and localization of Bio-Pharmaceutical medications.
القطاع
الأدوية والتكنولوجيا الحيوية
تحميل الفرصة
أبرز معالم الاستثمار
- Expected Investment size of USD (1.8 Billion for the whole segment and not capex / plant ( - capex/ plant is 375 Million)
- Plant capacity: Subjected to review ktpa
- Expected IRR: -Subjected to review %
- Payback period: Subjected to review years
- Job Creation: 330 till 2035 (Source NIS)
- GDP Impact: Subjected to review %